The projections come as National Cancer Institute data notes an increase in uterine cancer cases and deaths over the past 30 ...

While incidence and mortality rates for most cancer types have been on the decline in the United States, cases of uterine ...

Dr Ursula A. Matulonis comments on how endometrial cancer treatment is rapidly evolving with new immunotherapies and targeted ...

Personalized care may hold the key as survival in advanced endometrial cancer remains poor regardless of surgery type or ...

June is Uterine Cancer Awareness Month, and it's a crucial time to spotlight the warning signs of this increasingly deadly disease.Mandy Gaither reported that ...

In this video, Susana M. Campos, MD, MPH, discusses new research on adding metformin to letrozole/abemaciclib for the treatment of estrogen receptor-positive, recurrent endometrial cancer.The data ...

The classical endometrial cancer risk factors have been generally thought to act via estrogenic mechanisms, either by increasing estrogen exposure or opposing the effects of estrogen. 16 Obesity is ...

In the study, 64 patients with heavily pretreated advanced or recurrent endometrial cancer whose disease had progressed on or after an anti-PD-(L)1 and platinum-based chemotherapy were enrolled ...

The NHS has agreed a pair of commercial deals with Merck & Co/MSD and Eisai that will allow hundreds of women with advanced endometrial cancer to get access to life-extending combination therapy ...

By GSK's reckoning, there are around 60,000 new cases of endometrial cancer diagnosed each year in the US, with 15% to 20% of them at the advanced or metastatic stage. Of these, 20% to 29% are ...

The surgical management of endometrial cancer has been markedly changed by minimally invasive techniques. After three decades of laparoscopy, robotic surgery has built upon and expanded the ...